doc. MUDr. Jan Blatný, Ph.D.
Associate professor, Department of Pediatric Oncology
correspondence Address:
Černopolní 212/9, 662 63 Brno
phone: | +420 532 23 4244, 4428 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 83
2024
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
British journal of haematology, year: 2024, DOI
-
Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage
Journal of Clinical Medicine, year: 2024, volume: 13, edition: 9, DOI
-
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
Haemophilia, year: 2024, volume: 30, edition: 5, DOI
-
Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage
Journal of Clinical Medicine, year: 2024, volume: 13, edition: 10, DOI
2023
-
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
Annals of hematology, year: 2023, volume: 102, edition: 11, DOI
-
Capnometry during neonatal transport-Mini review
ACTA PAEDIATRICA, year: 2023, volume: 112, edition: 5, DOI
-
Considerations for shared decision management in previously untreated patients with hemophilia A or B
THERAPEUTIC ADVANCES IN HEMATOLOGY, year: 2023, volume: 14, edition: January-December 2023, DOI
-
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres
Haemophilia, year: 2023, volume: 29, edition: 5, DOI
-
Pediatric neurovascular complication of SARS-CoV-2 infection: A single Center Case-Series.
Year: 2023, type: Conference abstract
-
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication
Blood advances, year: 2023, volume: 7, edition: 9, DOI